乌克兰受伤外国战斗人员定植广泛耐药菌:全球传播潜在来源
23名(72%)患者携带全球流行克隆的耐碳青霉烯类肠球菌、肺炎克雷伯菌、鲍曼不动杆菌和铜绿假单胞菌,部分对头孢地尔或氨曲南-阿维巴坦不耐药。
要点
- 碳青霉烯酶、16S rRNA甲基转移酶和van操纵子基因共存,部分菌株对头孢地尔或氨曲南-阿维巴坦不耐药。
- 16名患者分离株与乌克兰患者分离株遗传相关,提示在乌克兰获得。
核心结论
- 乌克兰受伤外国战斗人员可定植广泛耐药菌,随 repatriation 可能挑战乌克兰及外国医疗系统的临床和感染防控。
研究设计与样本
- 2022年11月至2024年3月,对从乌克兰转至德国美军医院治疗的32名外籍战斗人员入院时采集直肠拭子,进行全基因组测序、耐药基因检测和药敏试验,并与乌克兰医院治疗士兵的分离株进行遗传相关性分析。
主要发现
- 23名(72%)患者携带属于全球流行克隆的粪肠球菌(ST117)、肺炎克雷伯菌(ST147、395)、鲍曼不动杆菌(ST78)和铜绿假单胞菌(ST235、ST773),这些菌株携带碳青霉烯酶(IMP、NDM、OXA)、16S rRNA甲基转移酶(ArmA、RmtB、RmtC)和/或van操纵子,其中14名患者有超过一种此类微生物。
- 16名战斗人员携带的分离株与乌克兰患者分离株遗传相关,提示在乌克兰获得。
- 药敏试验显示,8株对头孢地尔不耐药,6株对氨曲南-阿维巴坦不耐药,进一步复杂化产碳青霉烯酶菌株的治疗选择。
临床怎么用
- 对从乌克兰等冲突地区转入的战斗人员应进行多重耐药菌主动筛查,并考虑碳青霉烯酶和16S rRNA甲基转移酶基因检测。
- 治疗产碳青霉烯酶菌株感染时,需注意头孢地尔和氨曲南-阿维巴坦的不敏感可能,结合药敏结果选药。
- 加强感染预防与控制措施,防止广泛耐药菌在医疗系统内传播。
局限性
- 样本量较小(32名战斗人员),且为单中心研究,可能限制结果的普遍性。
- 仅基于直肠拭子筛查,未报告其他部位定植或感染情况。
- 未评估转归或传播动态。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Human conflicts are associated with increased prevalence of multi-drug-resistant organisms (MDROs). Here, we investigate a collection of extensively drug resistant (XDR) bacteria recovered from foreign combatants wounded in Ukraine and evacuated to a U.S. military treatment facility in Germany between November 2022 and March 2024. METHODS: As part of routine surveillance, perirectal swabs were collected upon admission from all patients arriving from outside Germany. Whole genome sequencing, antimicrobial resistance gene (AMR) carriage, and antimicrobial susceptibility testing (AST) was determined for all isolates. Genetic relatedness to a set of isolates from soldiers treated at Ukrainian hospitals was assessed. RESULTS: Eighty-six deduplicated clinically significant MDROs were cultured from 32 combatants from 10 countries injured in Ukraine and subsequently treated in Germany. Twenty-three (72%) patients carried isolates from well-established global lineages of Enterococcus faecium (ST117), Klebsiella pneumoniae (ST147, 395), Acinetobacter baumannii (ST78) and Pseudomonas aeruginosa (ST235, ST773) that harbored carbapenemase (IMP, NDM, OXA), a 16S rRNA methyltransferase (ArmA, RmtB, RmtC), and/or the van operon, with 14 patients having >1 of these organisms. Sixteen combatants carried isolates genetically related to those from Ukrainian patients, suggesting acquisition occurred in Ukraine. AST revealed multiple isolates non-susceptible to cefiderocol (n = 8) or aztreonam-avibactam (n = 6), further complicating treatment options for carbapenemase-producing organisms. CONCLUSIONS: This is the first study describing the epidemiology of MDROs collected from a population of foreign combatants injured in Ukraine. The findings forecast challenges to clinicians and infection prevention and control both in Ukraine and foreign healthcare systems as combatants are repatriated.
引用
- Mc Gann P, Luo TL, Martin MJ, et al. Foreign Combatants Wounded in Ukraine Colonized by Extensively Drug-Resistant Organisms: A Potential Source of Global Dissemination. J Infect Dis. 2026. PMID: 41128686. doi:10.1093/infdis/jiaf538
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。